Medical News Observer

Key Points

• ECHELON Synergy MRI System utilizes a 1.5 Tesla superconducting magnet and magnetic resonance technology to generate detailed cross-sectional images for diagnosing conditions in the head, body, and extremities.
• Manufactured by FUJIFILM Healthcare Corporation in Japan and FDA-approved under the 510(k) premarket notification, it meets substantial equivalence standards to prior models.
• This model features improvements over previous models, such as an open architecture design, and incorporates new technologies like Deep Learning Reconstruction, enhancing image quality and diagnostic capabilities.

 

Device Information

The ECHELON Synergy MRI System is a sophisticated imaging device utilizing a 1.5 Tesla superconducting magnet, designed to produce detailed cross-sectional images of the head, body, or extremities. It operates on the principle of magnetic resonance, using variations in the magnetic field and radiofrequency pulses to generate images from the hydrogen nuclei or protons in the body. This device is an evolution of the ECHELON OVAL V6.0A MRI system, featuring enhancements in clinical utility through its open architecture design.

Manufacturer Information

The ECHELON Synergy MRI System is manufactured by FUJIFILM Healthcare Corporation in Kashiwa-shi, Chiba, Japan. The company specializes in healthcare technologies, including diagnostic imaging systems.

Regulatory Approval Information

The U.S. Food and Drug Administration (FDA) cleared the ECHELON Synergy MRI System under the 510(k) premarket notification process. Under 21 CFR 892.1000, the FDA classifies this device as a Class II device with product code LNH and deems it substantially equivalent to its predicate, the ECHELON OVAL V6.0A MRI System.

Indications

The ECHELON Synergy MRI System is indicated for producing transverse, coronal, sagittal, oblique, and curved images of internal structures, assisting in diagnosing medical conditions without ionizing radiation. It is applicable for imaging various body parts, including the head, spine, and extremities.

Contraindications

Patients with certain types of metal implants, pacemakers, or other conditions sensitive to magnetic fields.

Study Results

Clinical testing has confirmed this system’s efficacy, and safety studies have shown that features like Deep Learning Reconstruction (DLR) enhance image quality compared to conventional methods. The system was tested against the recognized standards and confirmed for its image quality, safety, and performance.

Limitations

As with all MRI systems, the ECHELON Synergy has limitations, including sensitivity to patient movement. It is also susceptibile to artifacts from certain types of metal, and inherent contraindications for specific patient groups.

Conclusion

Advanced technological adaptations and regulatory approval confirm the ECHELON Synergy MRI System as a safe and effective medical imaging device. It maintains the core functionalities of its predicate device while incorporating enhancements that improve clinical utility and patient comfort.

Future Implications

The development of machine learning and advanced imaging techniques in MRI systems like the ECHELON Synergy are shaping the future. Diagnostic imaging is becoming more precise, efficient, and tailored to individual patient needs. This progression will likely expand MRI’s capabilities in medical diagnostics, potentially reducing the need for invasive diagnostic procedures.

Reference

ECHELON Synergy MRI System K223426 510(k) Premarket Notification.”  https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K223426.